mTOR inhibitors
Jan 09, 2017
mTOR Inhibitors-Emerging therapy in various therapeutic areas
Mammalian Target of Rapamycin (mTOR) is always in limelight for its wider application. It is a protein of a 289-kDa long chain contains serine and threonine kinase, and was first identified when rapamycin (Sirolimus) was discovered. mTOR helps in the synthesis of important cellular proteins which has a major impact ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
